Haploidentical 2ND ALLO-HSCT For Treatment of Acute Leukemia (AL) Relapse after 1ST ALLO-HSCT: Retrospective Registry Analysis of 63 PTS

被引：0

作者：

Christopeit, M. ^{[1
]}

Tischer, J. ^{[1
]}

Bornhaeuser, M. ^{[1
]}

Uharek, L. ^{[1
]}

Pfrepper, C. ^{[1
]}

Behre, G. ^{[1
]}

Niederwieser, D. ^{[1
]}

Kroeger, N. ^{[1
]}

Roesler, W. ^{[1
]}

Klein, S. ^{[1
]}

Hausmann, A. ^{[1
]}

Beelen, D. W. ^{[1
]}

Bethge, W. ^{[1
]}

Schmid, C. ^{[1
]}

机构：

[1] Univ Hamburg Hosp, Dept Stem Cell Transplantat, Hamburg, Germany

来源：

ANNALS OF HEMATOLOGY | 2015年 / 94卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S98 / S98

页数：1

共 50 条

[31] Retrospective analysis of standard allogeneic hematopoietic stem cell transplantation (allo-HSCT) for adult T-cell leukemia (ATL).
Fukushima, T
Miyazaki, Y
Kawano, F
Moriuchi, Y
Masuda, M
Tanosaki, R
Utsunomiya, A
Uike, N
Yoshida, S
Kuriyama, K
Tomonaga, M
BLOOD, 2002, 100 (11) : 456B - 457B
[32] Interleukin 11 induced capillary leakage syndrome and deteriorated hemorrhagic cystitis in an acute myelogenous leukemia patient after allo-HSCT
Sun, Xuemei
Yang, Yonggong
Guan, Chaoyang
Li, Xiaohui
BLOOD, 2007, 110 (11) : 327B - 327B
[33] CAR-T bridging to allo-HSCT as a treatment strategy for relapsed adult acute B-lymphoblastic leukemia: a case report
Shupeng Wen
Zhiyun Niu
Lina Xing
Ying Wang
Hang Li
Na Kuang
Jianmin Luo
Xuejun Zhang
Fuxu Wang
BMC Cancer, 18
[34] CAR-T bridging to allo-HSCT as a treatment strategy for relapsed adult acute B-lymphoblastic leukemia: a case report
Wen, Shupeng
Niu, Zhiyun
Xing, Lina
Wang, Ying
Li, Hang
Kuang, Na
Luo, Jianmin
Zhang, Xuejun
Wang, Fuxu
BMC CANCER, 2018, 18
[35] Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review
Li Gao
Jun Lu
Jie Li
Yixin Hu
Ye Lu
Weiwei Du
Shaoyan Hu
International Journal of Hematology, 2023, 117 : 781 - 785
[36] Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT
Sining Liu
Xueyi Luo
Xiaohui Zhang
Lanping Xu
Yu Wang
Chenhua Yan
Huan Chen
Yuhong Chen
Wei Han
Fengrong Wang
Jingzhi Wang
Kaiyan Liu
Xiaojun Huang
Xiaodong Mo
Scientific Reports, 10
[37] Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review
Gao, Li
Lu, Jun
Li, Jie
Hu, Yixin
Lu, Ye
Du, Weiwei
Hu, Shaoyan
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (05) : 781 - 785
[38] Patient-based prediction algorithm of relapse after allo-HSCT for acute Leukemia and its usefulness in the decision-making process using a machine learning approach
Fuse, Kyoko
Uemura, Shun
Tamura, Suguru
Suwabe, Tatsuya
Katagiri, Takayuki
Tanaka, Tomoyuki
Ushiki, Takashi
Shibasaki, Yasuhiko
Sato, Naoko
Yano, Toshio
Kuroha, Takashi
Hashimoto, Shigeo
Furukawa, Tatsuo
Narita, Miwako
Sone, Hirohito
Masuko, Masayoshi
CANCER MEDICINE, 2019, 8 (11): : 5058 - 5067
[39] T CELL EXHAUSTION CHARACTERIZED BY COMPROMISED MHC CLASS I AND II RESTRICTED CYTOTOXIC ACTIVITY ASSOCIATES WITH ACUTE B LYMPHOBLASTIC LEUKEMIA RELAPSE AFTER ALLO-HSCT
Liu, L.
Chang, Y.
Xu, L.
Zhang, X.
Wang, Y.
Liu, K.
Huang, X.
HAEMATOLOGICA, 2017, 102 : 193 - 193
[40] Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT
Liu, Sining
Luo, Xueyi
Zhang, Xiaohui
Xu, Lanping
Wang, Yu
Yan, Chenhua
Chen, Huan
Chen, Yuhong
Han, Wei
Wang, Fengrong
Wang, Jingzhi
Liu, Kaiyan
Huang, Xiaojun
Mo, Xiaodong
SCIENTIFIC REPORTS, 2020, 10 (01)

← 1 2 3 4 5 →